- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03069924
Gain-framed Messages and NRT for Lung Cancer Screening Patients
January 5, 2024 updated by: Benjamin Toll, Medical University of South Carolina
Gain-framed Messages and NRT Sampling to Promote Smoking Cessation in Lung Cancer Screening Programs
This research is a randomized smoking cessation trial conducted within and specifically personalized for lung cancer screening patients presenting to a lung screening clinic.
Novel tobacco treatments for this population are critically needed, given the growing population of lung screening patients, which will grow dramatically now that lung screening is an approved CMS benefit.
In the proposed study, we will test a gain-framed messaging intervention specifically designed for lung screening patients (vs.
unframed messaging), as well as evaluating NRT sampling (vs.
no medication) at 2 study sites.
Our project is designed to be translational (in that it can be transferable from our controlled efficacy study to other lung screening programs).
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
367
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Benjamin Toll, PhD
- Phone Number: 843-876-1132
- Email: toll@musc.edu
Study Contact Backup
- Name: Marian Chelsea Evangelista
- Phone Number: 843-509-7589
- Email: evangema@musc.edu
Study Locations
-
-
Connecticut
-
New Haven, Connecticut, United States, 06510
- Yale Cancer Center
-
-
South Carolina
-
Charleston, South Carolina, United States, 29425
- Medical University of South Carolina
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- 50 years or older
- at least a 20-pack year history of smoking
- current smoker (defined as any smoking in the past 30 days)
- willing to be randomized
- English speaking
Exclusion Criteria:
- unstable psychiatric/medical conditions such as suicidal ideation, acute psychosis, severe alcohol dependence, or dementia,
- known allergy to adhesives
- being in the immediate (within 2 weeks) post myocardial infarction period
- serious arrhythmias
- unstable angina pectoris
- hemodynamically or electrically unstable.
- current participation in another tobacco treatment program (e.g., using medication from a primary care doctor, Quitline, etc.)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: No NRT - Unframed Messaging
Unframed smoking cessation materials, but no NRT and no gain-framed messaging.
|
Unframed smoking cessation materials
|
Experimental: NRT plus Gain-framed Messaging
Gain-framed messaging plus NRT.
|
Gain-framed messaging materials and NRT
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Smoking cessation rates
Time Frame: 6 month follow-up
|
NRT+Gain-framed messaging vs.
No NRT+Unframed messaging
|
6 month follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Smoking cessation rates
Time Frame: 6 month follow-up
|
Gain-framed messaging + NRT & Unframed messaging + NRT vs. Gain-framed messaging + No NRT & Unframed messaging + No NRT
|
6 month follow-up
|
Smoking cessation rates
Time Frame: 6 month follow-up
|
Gain-framed messaging + NRT & Gain-framed messaging + No NRT vs. Unframed messaging + NRT & Unframed messaging + No NRT
|
6 month follow-up
|
Smoking cessation rates
Time Frame: 6 month follow-up
|
Gain-framed messaging + NRT & Gain-framed messaging + No NRT & Unframed messaging + NRT vs. Unframed messaging + No NRT
|
6 month follow-up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Benjamin Toll, PhD, Medical University of South Carolina
- Study Director: Alana Rojewski, PhD, Medical University of South Carolina
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2017
Primary Completion (Actual)
November 10, 2023
Study Completion (Estimated)
November 10, 2024
Study Registration Dates
First Submitted
February 28, 2017
First Submitted That Met QC Criteria
February 28, 2017
First Posted (Actual)
March 3, 2017
Study Record Updates
Last Update Posted (Actual)
January 9, 2024
Last Update Submitted That Met QC Criteria
January 5, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pro00055397
- 5R01CA207229-06 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Yes
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Smoking Cessation
-
University of Southern CaliforniaAmerican Cancer Society, Inc.CompletedSmoking | Smoking Cessation | Smoking, Cigarette | Smoking Behaviors | Cessation, SmokingUnited States
-
Nabi BiopharmaceuticalsNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco CessationUnited States
-
Claremont Graduate UniversityNational Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, CigaretteUnited States
-
Heidelberg UniversityPfizerTerminatedSmoking | Smoking Cessation | Tobacco Use CessationGermany
-
Mayo ClinicNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
-
University of MiamiFlorida Department of HealthRecruitingSmoking Cessation | Tobacco Smoking | Tobacco Use CessationUnited States
-
University of VermontMayo Clinic; Alaska Native Tribal Health ConsortiumTerminatedSmoking | Smoking CessationUnited States
-
University of Wisconsin, MadisonCentiment LLCCompletedSmoking | Smoking CessationUnited States
-
Yale UniversityCompletedSmoking | Smoking CessationUnited States
-
Johns Hopkins UniversityMaryland Department of Health and Mental HygieneCompletedCOach2Quit TRIAL: Assessing a Prototype Personal Carbon Monoxide Monitor for Smoking Cessation (C2Q)Smoking | Smoking CessationUnited States
Clinical Trials on Unframed messaging materials
-
Kaiser PermanenteNational Institute of Mental Health (NIMH)Completed
-
University of Alabama at BirminghamActive, not recruitingRAD 1601: EDGE Radiosurgery for Intractable Essential Tremor and Tremor-Dominant Parkinson's DiseaseParkinson Disease | Essential TremorUnited States
-
University of Massachusetts, WorcesterNational Institute on Drug Abuse (NIDA)Enrolling by invitationVaping | E-cigarette UseUnited States
-
Johns Hopkins Bloomberg School of Public HealthCompletedObesity | Weight Loss | mHealth | Healthy Diet
-
University of Alabama at BirminghamActive, not recruitingTrigeminal NeuralgiaUnited States
-
Washington University School of MedicineNational Cancer Institute (NCI)CompletedSmoking Cessation | Cancer | Health BehaviorUnited States
-
Penn State UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA); National Institutes...CompletedUnderage Drinking | Driving Under the Influence | Drinking, TeenUnited States
-
University College, LondonUniversity College London Hospitals; Homerton University Hospital NHS Foundation...Completed
-
Al-Azhar UniversityCompleted
-
Johns Hopkins Bloomberg School of Public HealthCenters for Medicare and Medicaid ServicesCompletedBreast Cancer | Lung Cancer | Prostate Cancer | Cervix Cancer | Colon Cancer | Rectum CancerUnited States